What research findings exist for Adipotide in fat reduction and obesity models?
Adipotide targeting white adipose tissue blood vessels reduces fat and improves insulin resistance. Additionally, research reports: targeting white adipose tissue blood vessels induces fat loss and improves metabolism, laying the foundation for adipotide.[1] ↗ [2] ↗
Currently, 2 original studies related to the theme of this page have been selected. Fewer than 3, leaving a gap, no supplementation from other sources. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.
Comparison of study design and results
Results from different populations, species, materials, or follow-up times cannot be directly combined. The table below is a comparative summary of published data, not new experimental data.
| Literature | Study subjects and design | Observation and discovery | Scope of Explanation |
|---|---|---|---|
| 2011 · PMID 22072637 | Obese Old World monkeys; Animal administration | Adipotide targeting white adipose tissue blood vessels reduces fat and improves insulin resistance. | 2011; Study also observed changes in renal proximal tubule function, cannot be promoted as a safe weight-loss injection. |
| 2004 · PMID 15133506 | Obese mice; Basic research on fat vascular targeting peptides | Targets white adipose tissue blood vessels to induce fat loss and improve metabolism, laying the foundation for adipotide. | 2004 Basic research, not a recent human report. |
References
What did fat targeting experiments observe in fat monkeys?
Adipotide targeting white adipose tissue blood vessels reduces fat and improves insulin resistance.[1] ↗
Obese Old World monkeys; Animal administration
2011; Study also observed changes in renal proximal tubule function, cannot be promoted as a safe weight-loss injection.
View the Article Title and Full Citation＋
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys.
Science Translational Medicine · Volume/Issue/Year 2011
First published on 2011-11-01 · PMID 22072637
DOI 10.1126/scitranslmed.3002621
What does basic research on fat vessel-targeted mice show?
Targets white adipose tissue blood vessels to induce fat loss and improve metabolism, laying the foundation for adipotide.[2] ↗
Obese mice; Basic research on fat vascular targeting peptides
2004 Basic research, not a recent human report.
View the Article Title and Full Citation＋
Reversal of obesity by targeted ablation of adipose tissue.
Nature medicine · Volume/Issue Year 2004
First published 2004-05-09 · PMID 15133506
DOI 10.1038/nm1048
Common issues and corresponding evidence
What research findings exist for Adipotide in fat reduction and obesity models?＋
Adipotide targeting white adipose tissue blood vessels reduces fat and improves insulin resistance. Additionally, research reports: targeting white adipose tissue blood vessels induces fat loss and improves metabolism, laying the foundation for adipotide.[1] ↗ [2] ↗
Is the evidence for Adipotide’s fat reduction based on human studies?＋
The direct studies on this page come from obese monkeys and mice, covering fat targeting and body weight changes; the human weight loss effect cannot yet be determined from this, and renal function changes observed in monkey studies cannot be omitted.[1] ↗ [2] ↗
Adipotide—these conclusions apply to which study populations?＋
Obese Old World monkey; Animal administration; Obese mice; Basic research on fatty vascular-targeting peptides. 2011; Studies also observed changes in proximal renal tubule function, which cannot be promoted as safe weight loss injections.[1] ↗ [2] ↗
Adipotide
Return to catalog specifications and batch file verification entry.
